Phase I Trial of Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer Intervention: Biological: Pemetrexed and donor-derived NK cell infusion Sponsors: Asan Medical Center; Korea Research Institute of Bioscience and Biotechnology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Biotechnology | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer